|
CTNNB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57319712812409E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14079881494445E-11 |
| Normal-vs-Stage2 |
1.659010E-03 |
| Normal-vs-Stage3 |
3.85009999992469E-07 |
| Normal-vs-Stage4 |
1.75099999999428E-05 |
| Stage1-vs-Stage2 |
3.535600E-01 |
| Stage1-vs-Stage3 |
3.781400E-01 |
| Stage1-vs-Stage4 |
4.305600E-01 |
| Stage2-vs-Stage3 |
7.280000E-01 |
| Stage2-vs-Stage4 |
7.609200E-01 |
| Stage3-vs-Stage4 |
9.905400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14630552114659E-11 |
| Normal-vs-AfricanAmerican |
8.31740000000192E-05 |
| Normal-vs-Asian |
9.77549999999772E-05 |
| Caucasian-vs-AfricanAmerican |
5.023700E-02 |
| Caucasian-vs-Asian |
9.827000E-01 |
| AfricanAmerican-vs-Asian |
5.488200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01669999999599E-05 |
| Normal-vs-Female |
1.73516756518666E-12 |
| Male-vs-Female |
1.027940E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61490043559809E-10 |
| Normal-vs-Age(41-60Yrs) |
5.1084000363133E-09 |
| Normal-vs-Age(61-80Yrs) |
1.155150E-04 |
| Normal-vs-Age(81-100Yrs) |
2.386900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.748600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.560010E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.428000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.472150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.553800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.638200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.077600E-01 |
| Classical-VS-Follicular |
1.09820000004923E-06 |
| Classical-VS-Other |
2.511600E-02 |
| Classical-VS-Normal |
1.64057656348859E-12 |
| Tall-VS-Follicular |
1.266050E-02 |
| Tall-VS-Other |
4.314400E-02 |
| Tall-VS-Normal |
8.04819999999928E-05 |
| Follicular-VS-Other |
5.180400E-01 |
| Follicular-VS-Normal |
5.218000E-02 |
| Other-VS-Normal |
9.523800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.75389999973663E-07 |
| Normal-vs-N1 |
1.417600E-03 |
| N0-vs-N1 |
7.982200E-01 |
|
|
